Skip to content

Benzonatate

Non-narcotic Antitussive — RESPIRATORY SYSTEM

Also known as: benzononantin, benzononatine, tessalon

FDA approvedATC R05DB01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Benzonatate is a drug in the Non-narcotic Antitussive class catalogued in DrugCentral. It was first approved by the FDA in 1958. DrugCentral lists 1 molecular target, including SCN5A. Recorded indications include Cough.

  • Drug class: Non-narcotic Antitussive.
  • Molecular targets: SCN5A (1 listed in DrugCentral).
  • Indications: Cough.
  • ATC code: R05DB01 (Other cough suppressants).
  • Molecular formula: C12H17NO2(C2H4O)7-9.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Cough

Mechanism & targets

Established pharmacologic classNon-narcotic Antitussive

Molecular targets (1)

TargetGeneActionActivity
Sodium channel protein type 5 subunit alphaSCN5Aunknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1958-02-10FDA—PFIZER

ATC classification

ATC codeTherapeutic hierarchy
R05DB01RESPIRATORY SYSTEM › COUGH AND COLD PREPARATIONS › COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS › Other cough suppressants

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Pneumonia298.5
Cough215.2
Bronchitis193.2
Product dose omission issue146.2
COVID-19120.4
Completed suicide119.3
Death115.9
Conduction disorder115.0
Dyspnoea97.0
Upper respiratory tract infection94.2
Influenza90.7
Maternal exposure during pregnancy88.2

Chemical structure

Molecular formulaC12H17NO2(C2H4O)7-9
Molecular weight—
CAS number104-31-4
InChIKey—
PubChem CID7699

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Benzonatate used for?

DrugCentral lists the following indications for Benzonatate: Cough.

How does Benzonatate work?

Its molecular targets in DrugCentral include SCN5A.

When was Benzonatate first approved?

Benzonatate was first approved by the FDA in 1958.

What drug class does Benzonatate belong to?

Benzonatate is in the Non-narcotic Antitussive class.

What is the chemical formula of Benzonatate?

Benzonatate has the molecular formula C12H17NO2(C2H4O)7-9.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1958-02-10
AgencyFDA
Targets1
Indications1
FormulaC12H17NO2(C2H4O)7-9
DrugCentral ID326
Interactive profile